The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice

Circulation. 2010 Nov 9;122(19):1948-56. doi: 10.1161/CIRCULATIONAHA.110.981365. Epub 2010 Oct 25.

Abstract

Background: The early components of the classical and lectin complement pathways have been shown to protect low-density lipoprotein receptor-deficient mice (Ldlr(-/-)) from early atherogenesis. However, the role of the alternative pathway remained unknown, and that was investigated in this study.

Methods and results: Mice lacking factor B (Bf(-/-)), the initiator of the alternative pathway, were crossed with Ldlr(-/-) mice and studied under different proatherogenic conditions. There was no statistically significant difference in lipid profiles or atherosclerotic lesion development between Bf(-/-)/Ldlr(-/-) and Ldlr(-/-) mice fed a low-fat diet. However, in these groups, administration of bacterial lipopolysaccharide led to a significant increase in atherosclerosis only in Ldlr(-/-) and not in Bf(-/-)/Ldlr(-/-) mice, indicating that the alternative pathway is necessary for endotoxin-mediated atherogenesis. Bf(-/-)/Ldlr(-/-) mice also had significantly decreased cross-sectional aortic root lesion fraction area and reduced lesion complexity compared with Ldlr(-/-) animals after a 12-week period of high-fat diet, although this was also accompanied by reduced levels of serum cholesterol. Under both experimental conditions, the atherosclerotic changes in the Bf(-/-)/Ldlr(-/-) mice were accompanied by a marked reduction in complement activation in the circulation and in atherosclerotic plaques, with no statistically significant differences in immunoglobulin G deposition or in the serum antibody response to oxidized low-density lipoprotein.

Conclusions: These data demonstrate that amplification of complement activation by the alternative pathway in response to lipopolysaccharide or high-fat diet plays a proatherogenic role.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / blood
  • Atherosclerosis / blood
  • Atherosclerosis / chemically induced
  • Atherosclerosis / immunology*
  • Atherosclerosis / pathology*
  • Complement Activation / genetics
  • Complement Activation / physiology
  • Complement C3 / metabolism
  • Complement C3a / metabolism
  • Complement Factor B / deficiency
  • Complement Pathway, Alternative / immunology*
  • Complement Pathway, Alternative / physiology
  • Complement System Proteins / metabolism
  • Diet, Atherogenic
  • Disease Models, Animal
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Lipopolysaccharides / toxicity
  • Lipoproteins, LDL / immunology
  • Mice
  • Mice, Knockout
  • Receptors, LDL / deficiency*

Substances

  • Antibodies
  • Complement C3
  • Immunoglobulin G
  • Lipopolysaccharides
  • Lipoproteins, LDL
  • Receptors, LDL
  • oxidized low density lipoprotein
  • Complement C3a
  • Complement System Proteins
  • Complement Factor B